Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Ferroptosis-IN-8

😃Good
Catalog No. T206031Cas No. 3056016-82-8
Alias Ferroptosis IN8

Ferroptosis-IN-8 (Compound B4) is a potent and specific small molecule inhibitor of ferroptosis, demonstrating a half-maximal inhibitory concentration (IC50) of 40.49 nM. it suppresses RSL3- or FIN56-induced ferroptosis through robust antioxidant mechanisms, alleviates models of hepatorenal injury, and shows significant potential in preventing a spectrum of ferroptosis-related diseases.

Ferroptosis-IN-8

Ferroptosis-IN-8

😃Good
Purity: 99.83%
Catalog No. T206031Alias Ferroptosis IN8Cas No. 3056016-82-8
Ferroptosis-IN-8 (Compound B4) is a potent and specific small molecule inhibitor of ferroptosis, demonstrating a half-maximal inhibitory concentration (IC50) of 40.49 nM. it suppresses RSL3- or FIN56-induced ferroptosis through robust antioxidant mechanisms, alleviates models of hepatorenal injury, and shows significant potential in preventing a spectrum of ferroptosis-related diseases.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$195-In Stock
5 mg$483-In Stock
10 mg$691-In Stock
25 mg$1,080-In Stock
50 mg$1,490-In Stock
100 mg$1,960-In Stock
200 mg$2,680-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.83%
Appearance:Solid
Color:Orange
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
Ferroptosis-IN-8 (Compound B4) is a potent and specific small molecule inhibitor of ferroptosis, demonstrating a half-maximal inhibitory concentration (IC50) of 40.49 nM. it suppresses RSL3- or FIN56-induced ferroptosis through robust antioxidant mechanisms, alleviates models of hepatorenal injury, and shows significant potential in preventing a spectrum of ferroptosis-related diseases.
Targets&IC50
Ferroptosis:40.49 nM
In vivo
Methods: Ferroptosis-IN-8 (10 mg/kg, intraperitoneal injection) was used to treat the acetaminophen-induced acute liver injury mouse model and its therapeutic effect was observed.
Results: Ferroptosis-IN-8 can reduce the increase of plasma ALT and AST in mice and reduce the liver injury response caused by acetaminophen. [1]
SynonymsFerroptosis IN8
Chemical Properties
Molecular Weight285.3
FormulaC15H15N3O3
Cas No.3056016-82-8
SmilesO=C(NN=CC1=CC=C(OC)C=C1)C=2C=CC=C(O)C2N
Relative Density.no data available
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 40 mg/mL (140.2 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM3.5051 mL17.5254 mL35.0508 mL175.2541 mL
5 mM0.7010 mL3.5051 mL7.0102 mL35.0508 mL
10 mM0.3505 mL1.7525 mL3.5051 mL17.5254 mL
20 mM0.1753 mL0.8763 mL1.7525 mL8.7627 mL
50 mM0.0701 mL0.3505 mL0.7010 mL3.5051 mL
100 mM0.0351 mL0.1753 mL0.3505 mL1.7525 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy Ferroptosis-IN-8 | purchase Ferroptosis-IN-8 | Ferroptosis-IN-8 cost | order Ferroptosis-IN-8 | Ferroptosis-IN-8 chemical structure | Ferroptosis-IN-8 in vivo | Ferroptosis-IN-8 formula | Ferroptosis-IN-8 molecular weight